---
title: National Eating Disorders Association (NEDA)
type: entity
entity_type: organization
domain: health
status: active
---

# National Eating Disorders Association (NEDA)

Leading U.S. advocacy and clinical guidance organization for eating disorder treatment and prevention.

## Timeline

- **2025-01-01** — Published joint clinical guidance with ANAD on GLP-1 receptor agonist use in eating disorder populations, recommending tri-specialist care teams and identifying contraindications including current/past anorexia nervosa, active restrictive behaviors, and severe body image issues

## Overview

NEDA provides clinical guidance, advocacy, and resources for eating disorder treatment. Their recommendations carry professional authority but no regulatory force—guidance creates clinical standards without legal mandates.

## Key Positions

**GLP-1 Contraindications (2025):**
- Current or past anorexia nervosa or atypical anorexia nervosa
- Active restrictive behaviors, bingeing, or purging
- Severe body image issues or unstable recovery
- Lack of appropriate monitoring or multidisciplinary support
- Signs the medication is being sought solely for weight loss

NEDA notes there are no FDA warnings for eating disorder populations—all guidance is professional society recommendation only.